Search Results - "Krumholz, Harlan M"

Post-Hospital Syndrome — An Acquired, Transient Condition of Generalized Risk by Krumholz, Harlan M

“…Patients who were recently hospitalized experience a period of generalized risk for myriad adverse health events. Their condition may be characterized as a…”
Get full text

Using Latent Class Analysis to Identify Hidden Clinical Phenotypes by Mori, Makoto, Krumholz, Harlan M, Allore, Heather G

“…This JAMA Guide to Statistics and Methods summarizes latent class analysis, a statistical technique that estimates the probability of patients belonging to a…”
Get full text

Is Hemoglobin A1c the Right Outcome for Studies of Diabetes? by Lipska, Kasia J, Krumholz, Harlan M

Get full text

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study by Khera, Rohan, Lu, Yuan, Lu, Jiapeng, Saxena, Anshul, Nasir, Khurram, Jiang, Lixin, Krumholz, Harlan M

“…AbstractObjectiveTo examine the effect of the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines on the…”
Get full text

Increasing value and reducing waste: addressing inaccessible research by Chan, An-Wen, Dr, Song, Fujian, Prof, Vickers, Andrew, PhD, Jefferson, Tom, MD, Dickersin, Kay, Prof, Gøtzsche, Peter C, Prof, Krumholz, Harlan M, Prof, Ghersi, Davina, PhD, van der Worp, H Bart, PhD

“…Summary The methods and results of health research are documented in study protocols, full study reports (detailing all analyses), journal reports, and…”
Get full text

Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project) by Lu, Jiapeng, Lu, Yuan, Wang, Xiaochen, Li, Xinyue, Linderman, George C, Wu, Chaoqun, Cheng, Xiuyuan, Mu, Lin, Zhang, Haibo, Liu, Jiamin, Su, Meng, Zhao, Hongyu, Spatz, Erica S, Spertus, John A, Masoudi, Frederick A, Krumholz, Harlan M, Jiang, Lixin

“…Hypertension is common in China and its prevalence is rising, yet it remains inadequately controlled. Few studies have the capacity to characterise the…”
Get full text

ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data by Li, Jing, PhD, Li, Xi, PhD, Wang, Qing, MS, Hu, Shuang, PhD, Wang, Yongfei, MS, Masoudi, Frederick A, Prof, Spertus, John A, Prof, Krumholz, Harlan M, Prof, Jiang, Lixin, Prof

“…Summary Background Despite the importance of ST-segment elevation myocardial infarction (STEMI) in China, no nationally representative studies have…”
Get full text

Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study by Chekroud, Sammi R, Gueorguieva, Ralitza, Zheutlin, Amanda B, Paulus, Martin, Krumholz, Harlan M, Krystal, John H, Chekroud, Adam M

“…Exercise is known to be associated with reduced risk of all-cause mortality, cardiovascular disease, stroke, and diabetes, but its association with mental…”
Get full text

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis by Suchard, Marc A, Schuemie, Martijn J, Krumholz, Harlan M, You, Seng Chan, Chen, RuiJun, Pratt, Nicole, Reich, Christian G, Duke, Jon, Madigan, David, Hripcsak, George, Ryan, Patrick B

“…Uncertainty remains about the optimal monotherapy for hypertension, with current guidelines recommending any primary agent among the first-line drug classes…”
Get full text

Quality of primary health care in China: challenges and recommendations by Li, Xi, Krumholz, Harlan M, Yip, Winnie, Cheng, Kar Keung, De Maeseneer, Jan, Meng, Qingyue, Mossialos, Elias, Li, Chuang, Lu, Jiapeng, Su, Meng, Zhang, Qiuli, Xu, Dong Roman, Li, Liming, Normand, Sharon-Lise T, Peto, Richard, Li, Jing, Wang, Zengwu, Yan, Hongbing, Gao, Runlin, Chunharas, Somsak, Gao, Xin, Guerra, Raniero, Ji, Huijie, Ke, Yang, Pan, Zhigang, Wu, Xianping, Xiao, Shuiyuan, Xie, Xinying, Zhang, Yujuan, Zhu, Jun, Zhu, Shanzhu, Hu, Shengshou

“…China has substantially increased financial investment and introduced favourable policies for strengthening its primary health care system with core…”
Get full text

Trends in Acute Myocardial Infarction in Young Patients and Differences by Sex and Race, 2001 to 2010 by Gupta, Aakriti, MBBS, Wang, Yongfei, MS, Spertus, John A., MD, MPH, Geda, Mary, MSN, Lorenze, Nancy, DNSc, MSN, Nkonde-Price, Chileshe, MD, D'Onofrio, Gail, MD, MS, Lichtman, Judith H., PhD, MPH, Krumholz, Harlan M., MD, SM

“…Abstract Background Various national campaigns launched in recent years have focused on young women with acute myocardial infarctions (AMIs). Contemporary…”
Get full text

National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 by Chen, Jersey, Normand, Sharon-Lise T, Wang, Yun, Krumholz, Harlan M

“…CONTEXT It is not known whether recent declines in ischemic heart disease and its risk factors have been accompanied by declines in heart failure (HF)…”
Get full text

Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions by Desai, Nihar R, Ross, Joseph S, Kwon, Ji Young, Herrin, Jeph, Dharmarajan, Kumar, Bernheim, Susannah M, Krumholz, Harlan M, Horwitz, Leora I

“…IMPORTANCE: Readmission rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which penalizes hospitals for excess…”
Get full text

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension by Hripcsak, George, Suchard, Marc A, Shea, Steven, Chen, RuiJun, You, Seng Chan, Pratt, Nicole, Madigan, David, Krumholz, Harlan M, Ryan, Patrick B, Schuemie, Martijn J

“…Chlorthalidone is currently recommended as the preferred thiazide diuretic to treat hypertension, but no trials have directly compared risks and benefits. To…”
Get more information

All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 by Faust, Jeremy Samuel, Krumholz, Harlan M, Du, Chengan, Mayes, Katherine Dickerson, Lin, Zhenqiu, Gilman, Cleavon, Walensky, Rochelle P

“…Faust et al discuss the study which compares all-cause excess mortality and COVID-19-related mortality during the early pandemic period (March-July 2020) with…”
Get full text

Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov by Pundi, Krishna, Perino, Alexander C, Harrington, Robert A, Krumholz, Harlan M, Turakhia, Mintu P

Get more information

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013 by Lipska, Kasia J, Yao, Xiaoxi, Herrin, Jeph, McCoy, Rozalina G, Ross, Joseph S, Steinman, Michael A, Inzucchi, Silvio E, Gill, Thomas M, Krumholz, Harlan M, Shah, Nilay D

“…To examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2…”
Get full text

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011 by Krumholz, Harlan M, Normand, Sharon-Lise T, Wang, Yun

“…BACKGROUND—During the past decade, efforts focused intensely on improving the quality of care for people with, or at risk for, cardiovascular disease and…”
Get full text

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010 by Downing, Nicholas S, Shah, Nilay D, Aminawung, Jenerius A, Pease, Alison M, Zeitoun, Jean-David, Krumholz, Harlan M, Ross, Joseph S

“…IMPORTANCE: Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of…”
Get full text

Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study by Nallamothu, Brahmajee K, Dr, Normand, Sharon-Lise T, Prof, Wang, Yongfei, MSc, Hofer, Timothy P, Prof, Brush, John E, Prof, Messenger, John C, MD, Bradley, Elizabeth H, Prof, Rumsfeld, John S, Prof, Krumholz, Harlan M, Prof

“…Summary Background Recent reductions in average door-to-balloon (D2B) times have not been associated with decreases in mortality at the population level. We…”
Get full text